As healthcare professionals, our priority is your overall health
You may stay on just the starting dose and be just fine
GLP-1RAs, which increase satiety and reduce hunger and increasing satiety could exacerbate dietary restriction (i.e., physiological undereating) and dietary restraint (i.e., the cognitive effort to reduce food intake) by encouraging the adoption of extreme and rigid dietary rules (see Figure 1)
Patients must have a BMI of over 30 or a BMI over 27 in combination with an obesity-related medical condition
Because obesity is considered a long-term, relapsing metabolic condition, ongoing treatment is often necessary to maintain results
While some medications can be delivered through the skinsuch as estrogen patches used in hormone therapythere are currently no weight loss patches on the market that contain FDA-approved ingredients